Radiation Therapy for Non-Small Cell Lung Cancer

May 5, 2015
Cat Snyder, ASCO staff

Guidelines shape the way doctors approach treatment through findings from current research. Dr. Andreas Rimner, from Memorial Sloan Kettering Cancer Center in New York City, shares that “guidelines can provide a framework of what the best evidence is to date.”

Recently, the American Society of Radiation Oncology (ASTRO) produced a guideline to direct the way that doctors use external-beam radiation therapy for treatment of locally advanced non-small cell lung cancer (NSCLC), which ASCO endorses. For these guideline endorsements, ASCO assembles a committee of doctors, health care providers, and patient advocates to evaluate whether the research supports the guideline’s recommendations.

In this podcast, you’ll hear from two members of ASCO’s guideline committee who worked on this endorsement. Dr. Andreas Rimner and Dr. John Robert Strawn, who is a doctor and patient advocate, provide an expert perspective on what this endorsement means for the use of radiation for treatment of NSCLC.

Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer

This is a prerecorded audio podcast, and it can be listened to online or downloaded to your computer. A transcript of this podcast is also available. For more information, visit the Cancer.Net podcast page.


Share your thoughts on this blog post on Cancer.Net's Facebook and Twitter.